aqua pharma ltd
aqua pharma ltd Company Information
Company Number
SC369585
Next Accounts
Sep 2025
Industry
Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
Shareholders
aqua pharma group as
Group Structure
View All
Contact
Registered Address
4th floor metropolitan house, 31-33 high street, inverness, IV1 1HT
Website
www.aqua-pharma.comaqua pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of AQUA PHARMA LTD at £1.4m based on a Turnover of £2.8m and 0.51x industry multiple (adjusted for size and gross margin).
aqua pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of AQUA PHARMA LTD at £0 based on an EBITDA of £-667.3k and a 4.38x industry multiple (adjusted for size and gross margin).
aqua pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of AQUA PHARMA LTD at £4.6m based on Net Assets of £2m and 2.32x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Aqua Pharma Ltd Overview
Aqua Pharma Ltd is a live company located in inverness, IV1 1HT with a Companies House number of SC369585. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in December 2009, it's largest shareholder is aqua pharma group as with a 100% stake. Aqua Pharma Ltd is a established, small sized company, Pomanda has estimated its turnover at £2.8m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Aqua Pharma Ltd Health Check
Pomanda's financial health check has awarded Aqua Pharma Ltd a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 3 areas for improvement. Company Health Check FAQs
5 Strong
4 Regular
3 Weak
Size
annual sales of £2.8m, make it in line with the average company (£2.8m)
- Aqua Pharma Ltd
£2.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 7%, show it is growing at a similar rate (7.1%)
- Aqua Pharma Ltd
7.1% - Industry AVG
Production
with a gross margin of 44.9%, this company has a comparable cost of product (44.9%)
- Aqua Pharma Ltd
44.9% - Industry AVG
Profitability
an operating margin of -25.8% make it less profitable than the average company (5.7%)
- Aqua Pharma Ltd
5.7% - Industry AVG
Employees
with 5 employees, this is below the industry average (21)
5 - Aqua Pharma Ltd
21 - Industry AVG
Pay Structure
on an average salary of £52.9k, the company has an equivalent pay structure (£52.9k)
- Aqua Pharma Ltd
£52.9k - Industry AVG
Efficiency
resulting in sales per employee of £559.4k, this is more efficient (£125.2k)
- Aqua Pharma Ltd
£125.2k - Industry AVG
Debtor Days
it gets paid by customers after 103 days, this is later than average (56 days)
- Aqua Pharma Ltd
56 days - Industry AVG
Creditor Days
its suppliers are paid after 44 days, this is slower than average (31 days)
- Aqua Pharma Ltd
31 days - Industry AVG
Stock Days
it holds stock equivalent to 20 days, this is less than average (29 days)
- Aqua Pharma Ltd
29 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 185 weeks, this is more cash available to meet short term requirements (26 weeks)
185 weeks - Aqua Pharma Ltd
26 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 15.3%, this is a lower level of debt than the average (53%)
15.3% - Aqua Pharma Ltd
53% - Industry AVG
AQUA PHARMA LTD financials
Aqua Pharma Ltd's latest turnover from December 2023 is estimated at £2.8 million and the company has net assets of £2 million. According to their latest financial statements, Aqua Pharma Ltd has 5 employees and maintains cash reserves of £1.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 5,874,403 | 9,247,309 | 14,954,973 | 14,954,973 | 12,829,786 | |||||||||
| Other Income Or Grants | 0 | 0 | 0 | 0 | 0 | |||||||||
| Cost Of Sales | 3,907,624 | 7,105,552 | 11,464,980 | 11,464,980 | 9,453,574 | |||||||||
| Gross Profit | 1,966,779 | 2,141,757 | 3,489,993 | 3,489,993 | 3,376,212 | |||||||||
| Admin Expenses | 930,336 | 916,486 | 636,583 | 636,583 | 594,651 | |||||||||
| Operating Profit | 1,036,443 | 1,225,271 | 2,853,410 | 2,853,410 | 2,781,561 | |||||||||
| Interest Payable | 1,900 | 0 | 1,246 | 1,884 | 0 | |||||||||
| Interest Receivable | 0 | 19,649 | 72,475 | 58,873 | 4,401 | |||||||||
| Pre-Tax Profit | 1,034,543 | 1,244,920 | 1,652,316 | 3,012,570 | 2,785,962 | |||||||||
| Tax | -198,348 | -239,076 | -328,043 | -584,053 | -603,265 | |||||||||
| Profit After Tax | 836,195 | 1,005,844 | 1,324,273 | 2,428,517 | 2,182,697 | |||||||||
| Dividends Paid | 0 | 2,729,569 | 1,000,000 | 688,000 | 1,059,400 | |||||||||
| Retained Profit | 836,195 | -1,723,725 | 324,273 | 1,740,517 | 1,123,297 | |||||||||
| Employee Costs | 299,543 | 255,138 | 228,159 | 246,417 | ||||||||||
| Number Of Employees | 5 | 5 | 5 | 7 | 7 | 7 | 7 | 7 | 8 | 7 | ||||
| EBITDA* | 1,424,038 | 1,597,410 | 3,044,543 | 3,002,679 | 2,947,310 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 44,235 | 35,614 | 208,505 | 420,473 | 992,255 | 1,177,654 | 1,279,108 | 1,019,262 | 562,320 | 553,581 | 349,238 | 123,049 | 58,377 | 3,274 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 479 | 479 | 79 | 79 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1,357,207 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 44,235 | 35,614 | 208,505 | 420,473 | 992,255 | 1,177,654 | 1,279,108 | 1,019,262 | 562,320 | 1,911,267 | 349,717 | 123,128 | 58,456 | 3,274 |
| Stock & work in progress | 84,498 | 157,333 | 236,878 | 249,406 | 430,280 | 173,526 | 635,202 | 699,258 | 595,714 | 522,872 | 331,279 | 147,526 | 73,752 | 0 |
| Trade Debtors | 796,251 | 384,066 | 280,353 | 597,669 | 320,282 | 527,599 | 274,612 | 1,141,733 | 1,814,548 | 1,001,838 | 1,270,431 | 314,748 | 215,831 | 96,037 |
| Group Debtors | 16,146 | 81,161 | 214,457 | 311,358 | 309,016 | 83,985 | 128,353 | 1,877,152 | 2,345,188 | 375,375 | 0 | 0 | 0 | 0 |
| Misc Debtors | 121,019 | 18,729 | 98,526 | 0 | 0 | 2,057 | 61,226 | 77,596 | 3,600 | 25,688 | 0 | 0 | 0 | 0 |
| Cash | 1,283,114 | 2,299,759 | 2,454,914 | 2,056,823 | 3,538,638 | 2,840,349 | 1,004,782 | 299,981 | 196,236 | 489,221 | 1,186,979 | 265,521 | 106,023 | 5,012 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 2,301,028 | 2,941,048 | 3,285,128 | 3,215,256 | 4,598,216 | 3,627,516 | 2,104,175 | 4,095,720 | 4,955,286 | 2,414,994 | 2,788,689 | 727,795 | 395,606 | 101,049 |
| total assets | 2,345,263 | 2,976,662 | 3,493,633 | 3,635,729 | 5,590,471 | 4,805,170 | 3,383,283 | 5,114,982 | 5,517,606 | 4,326,261 | 3,138,406 | 850,923 | 454,062 | 104,323 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 186,821 | 6,517 | 12,823 | 80,263 | 711,690 | 742,638 | 177,195 | 114,059 | 582,953 | 1,094,828 | 1,508,273 | 382,027 | 362,677 | 89,774 |
| Group/Directors Accounts | 17,573 | 183,147 | 28,763 | 78,425 | 14,880 | 18,716 | 20,262 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 155,198 | 173,120 | 182,028 | 543,388 | 332,225 | 343,827 | 31,534 | 117,856 | 387,707 | 430,138 | 0 | 0 | 0 | 0 |
| total current liabilities | 359,592 | 362,784 | 223,614 | 702,076 | 1,058,795 | 1,105,181 | 228,991 | 231,915 | 970,660 | 1,524,966 | 1,508,273 | 382,027 | 362,677 | 89,774 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 12,989 | 96,439 | 100,947 | 116,701 | 121,751 | 109,903 | 104,769 | 56,904 | 13,988 | 11,675 | 0 |
| total long term liabilities | 0 | 0 | 0 | 12,989 | 96,439 | 100,947 | 116,701 | 121,751 | 109,903 | 104,769 | 56,904 | 13,988 | 11,675 | 0 |
| total liabilities | 359,592 | 362,784 | 223,614 | 715,065 | 1,155,234 | 1,206,128 | 345,692 | 353,666 | 1,080,563 | 1,629,735 | 1,565,177 | 396,015 | 374,352 | 89,774 |
| net assets | 1,985,671 | 2,613,878 | 3,270,019 | 2,920,664 | 4,435,237 | 3,599,042 | 3,037,591 | 4,761,316 | 4,437,043 | 2,696,526 | 1,573,229 | 454,908 | 79,710 | 14,549 |
| total shareholders funds | 1,985,671 | 2,613,878 | 3,270,019 | 2,920,664 | 4,435,237 | 3,599,042 | 3,037,591 | 4,761,316 | 4,437,043 | 2,696,526 | 1,573,229 | 454,908 | 79,710 | 14,549 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||||||
| Operating Profit | 1,036,443 | 1,225,271 | 2,853,410 | 2,853,410 | 2,781,561 | |||||||||
| Depreciation | 54,938 | 180,019 | 288,053 | 344,943 | 387,595 | 348,459 | 372,139 | 191,133 | 149,269 | 165,749 | 79,824 | 31,939 | 19,459 | 1,091 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | -198,348 | -239,076 | -328,043 | -584,053 | -603,265 | |||||||||
| Stock | -72,835 | -79,545 | -12,528 | -180,874 | 256,754 | -461,676 | -64,056 | 103,544 | 72,842 | 191,593 | 183,753 | 73,774 | 73,752 | 0 |
| Debtors | 449,460 | -109,380 | -315,691 | 279,729 | 15,657 | 149,450 | -2,632,290 | -1,066,855 | 1,403,228 | 1,489,677 | 955,683 | 98,917 | 119,794 | 96,037 |
| Creditors | 180,304 | -6,306 | -67,440 | -631,427 | -30,948 | 565,443 | 63,136 | -468,894 | -511,875 | -413,445 | 1,126,246 | 19,350 | 272,903 | 89,774 |
| Accruals and Deferred Income | -17,922 | -8,908 | -361,360 | 211,163 | -11,602 | 312,293 | -86,322 | -269,851 | -42,431 | 430,138 | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | -12,989 | -83,450 | -4,508 | -15,754 | -5,050 | 11,848 | 5,134 | 47,865 | 42,916 | 2,313 | 11,675 | 0 |
| Cash flow from operations | 906,221 | 4,026,444 | 2,952,914 | 393,384 | 727,333 | |||||||||
| Investing Activities | ||||||||||||||
| capital expenditure | ||||||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -479 | 0 | 400 | 0 | 79 | 0 |
| cash flow from investments | ||||||||||||||
| Financing Activities | ||||||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | -165,574 | 154,384 | -49,662 | 63,545 | -3,836 | -1,546 | 20,262 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||||||||||
| interest | -1,900 | 19,649 | 71,229 | 56,989 | 4,401 | |||||||||
| cash flow from financing | -5,736 | 39,911 | 71,229 | 56,989 | 4,401 | |||||||||
| cash and cash equivalents | ||||||||||||||
| cash | -1,016,645 | -155,155 | 398,091 | -1,481,815 | 698,289 | 1,835,567 | 704,801 | 103,745 | -292,985 | -697,758 | 921,458 | 159,498 | 101,011 | 5,012 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -1,016,645 | -155,155 | 398,091 | -1,481,815 | 698,289 | 1,835,567 | 704,801 | 103,745 | -292,985 | -697,758 | 921,458 | 159,498 | 101,011 | 5,012 |
aqua pharma ltd Credit Report and Business Information
Aqua Pharma Ltd Competitor Analysis
Perform a competitor analysis for aqua pharma ltd by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in IV1 area or any other competitors across 12 key performance metrics.
aqua pharma ltd Ownership
AQUA PHARMA LTD group structure
Aqua Pharma Ltd has no subsidiary companies.
Ultimate parent company
AQUA PHARMA GROUP AS
#0149051
1 parent
AQUA PHARMA LTD
SC369585
aqua pharma ltd directors
Aqua Pharma Ltd currently has 3 directors. The longest serving directors include Mr Elvin Bugge (Dec 2012) and Mrs Hanne Mertens (Jan 2020).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Elvin Bugge | United Kingdom | 65 years | Dec 2012 | - | Director |
| Mrs Hanne Mertens | United Kingdom | 44 years | Jan 2020 | - | Director |
| Mrs Hanne Mertens | United Kingdom | 44 years | Jan 2020 | - | Director |
P&L
December 2023turnover
2.8m
+105%
operating profit
-722.3k
0%
gross margin
44.9%
+2.24%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
2m
-0.24%
total assets
2.3m
-0.21%
cash
1.3m
-0.44%
net assets
Total assets minus all liabilities
aqua pharma ltd company details
company number
SC369585
Type
Private limited with Share Capital
industry
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
December 2009
age
15
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
aquapharma ltd. (January 2010)
accountant
FRAME KENNEDY LTD
auditor
-
address
4th floor metropolitan house, 31-33 high street, inverness, IV1 1HT
Bank
DNB
Legal Advisor
-
aqua pharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to aqua pharma ltd.
aqua pharma ltd Companies House Filings - See Documents
| date | description | view/download |
|---|
